$ABBV · AbbVie Inc.

AbbVie Inc. filed a Form 4 with the SEC reporting a change in beneficial ownership for Susan E. Quaggin, a member of the company’s board of directors. The filing shows that on September 30, 2026, Quaggin acquired 59 stock equivalent units at a price of $261.59 per unit. These units are not direct common stock purchases but represent director fees credited to an unfunded book account in her name.

According to the filing, the stock equivalent units earn the same return as if the fees were invested in AbbVie stock. They are generally distributed over a period equal to the director’s years of board service, beginning at the later of age 65 or retirement from the board. After the reported transaction, Quaggin beneficially owned 918 stock equivalent units. The balance includes additional units acquired through a dividend reinvestment feature. The Form 4 was signed on October 2, 2026, by an attorney-in-fact on behalf of Quaggin.